Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1F31CA250161-01
Characterization of circadian rhythms in Glioblastoma multiforme and investigation of chronotherapy as a novel therapy to prolong patient survival
National Institutes of Health
Grant: 1T32NS121881-01
Neuroscience Training Program at Washington University
European Commission
Grant: 120003
MOdeling and DEsign of Reliable, process variation-aware Nanoelectronic devices, circuits and systems
National Institutes of Health
Grant: 5R25GM103757-08
MAXIMIZING STUDENT DIVERSITY IN THE BIOMEDICAL SCIENCES AT WASHINGTON UNIVERSITY
National Institutes of Health
Grant: 5R21NS120003-02
Chronotherapy for glioblastoma
Fields of Study
Keywords
Sustainable Development Goals